Abiopharma

New Form 8-K - Marker Therapeutics, Inc. Filed: 2025-08-26 AccNo: 0001104659-25-082783 Size: 10 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits